Financial giants have made a conspicuous bullish switch on Viking Therapeutics. Our analysis of decisions historic previous for Viking Therapeutics (NASDAQ:VKTX) revealed 11 unusual trades.
Delving into the small print, we found 45% of retailers had been bullish, whereas 36% confirmed bearish tendencies. Out of the entire trades we observed, 2 had been locations, with a value of $78,002, and 9 had been calls, valued at $1,174,199.
Anticipated Worth Actions
After evaluating the shopping for and promoting volumes and Open Curiosity, it’s evident that an important market movers are specializing in a price band between $68.0 and $130.0 for Viking Therapeutics, spanning the ultimate three months.
Insights into Amount & Open Curiosity
Inspecting the quantity and open curiosity offers important insights into stock evaluation. This knowledge is significant in gauging liquidity and curiosity ranges for Viking Therapeutics’s decisions at certain strike prices. Beneath, we present a snapshot of the developments in amount and open curiosity for calls and locations all through Viking Therapeutics’s necessary trades, inside a strike worth differ of $68.0 to $130.0, over the earlier month.
Viking Therapeutics Risk Amount And Open Curiosity Over Closing 30 Days
Noteworthy Decisions Train:
| Picture | PUT/CALL | Commerce Sort | Sentiment | Exp. Date | Ask | Bid | Worth | Strike Worth | Entire Commerce Worth | Open Curiosity | Amount |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VKTX | CALL | TRADE | BEARISH | 08/16/24 | $10.4 | $9.6 | $9.7 | $80.00 | $582.0K | 419 | 7 |
| VKTX | CALL | TRADE | BULLISH | 06/21/24 | $6.5 | $4.5 | $6.5 | $75.00 | $110.5K | 2.6K | 184 |
| VKTX | CALL | SWEEP | NEUTRAL | 06/21/24 | $6.3 | $6.0 | $6.3 | $75.00 | $107.1K | 2.6K | 355 |
| VKTX | CALL | TRADE | BEARISH | 06/21/24 | $5.2 | $4.9 | $4.9 | $80.00 | $83.3K | 2.2K | 214 |
| VKTX | CALL | TRADE | BULLISH | 06/21/24 | $6.5 | $6.0 | $6.4 | $75.00 | $81.2K | 2.6K | 483 |
About Viking Therapeutics
Viking Therapeutics Inc is a healthcare service provider. The company specializes inside the area of biopharmaceutical development centered on metabolic and endocrine points. The company’s medical program pipeline consists of VK2809, VK5211, VK0214 merchandise. VK2809 and VK0214 are orally on the market, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally on the market, non-steroidal selective androgen receptor modulator.
Following our analysis of the alternatives actions associated to Viking Therapeutics, we pivot to a extra in-depth check out the company’s private effectivity.
Viking Therapeutics’s Current Market Standing
With a shopping for and promoting amount of 1,399,686, the price of VKTX is down by -0.64%, reaching $68.62.
Current RSI values level out that the stock is may be approaching overbought.
Subsequent earnings report is scheduled for 68 days from now.
Skilled Opinions on Viking Therapeutics
3 market consultants haven’t too way back issued rankings for this stock, with a consensus purpose worth of $108.66666666666667.
An analyst from HC Wainwright & Co. downgraded its movement to Buy with a price purpose of $90.
Reflecting points, an analyst from Truist Securities lowers its rating to Buy with a model new worth purpose of $120.
Displaying optimism, an analyst from Raymond James upgrades its rating to Sturdy Buy with a revised worth purpose of $116.
Decisions shopping for and promoting presents better risks and potential rewards. Astute retailers deal with these risks by often educating themselves, adapting their strategies, monitoring a variety of indicators, and holding an in depth eye on market actions. Hold educated regarding the latest Viking Therapeutics decisions trades with real-time alerts from Benzinga Skilled.
© 2024 Benzinga.com. Benzinga does not current funding advice. All rights reserved.
Watch Additional
The views and opinions expressed herein are the views and opinions of the author and do not basically mirror these of Nasdaq, Inc.
Provide hyperlink
